₹1,722.2
▲ +6.86 +0.40%
17 Jul 2026
BSE Listed · Healthcare
Poly Medicure Ltd. (531768)
Volume: 9,548Avg Vol 1W: 8,059Avg Vol 1M: 12,74652W Range:₹1,184₹2,165.95
Key Ratios
Checked just nowMarket Cap₹17,456 Cr
Current Price₹1,722.2
Previous Close₹1,715.34
High / Low (52w)₹2,165.95 / ₹1,184
Volume9,548
Avg Vol (1W)8,059
Avg Vol (1M)12,746
Stock P/E263.33
Book Value₹306.45
Dividend Yield20%
ROE10.37%
ROA8.18%
Revenue (TTM)—
Revenue Growth21.37%
Profit Margin17.18%
Total Debt₹0 Cr
Shares Outstanding10 Cr
Face Value₹5
EPS (TTM)₹32.29
P/B5.62
Debt / Equity0.11
50 DMA₹1,559.95
200 DMA₹1,627.65
Day change+0.40%
Price Chart
₹1,722.2▼ 18.26% · 1Y
2025-07-162026-07-16
20-day avg volume: 13K shares
Pros
- Pays a dividend yield of 20.0%.
- Company is almost debt-free.
- Revenue grew 23% YoY.
- Net profit is growing year over year.
Cons
- Stock trades at a high P/E of 263.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹385 Cr | ₹420 Cr | ₹424 Cr | ₹441 Cr | ₹403 Cr | ₹444 Cr | ₹494 Cr | ₹535 Cr |
| EBITDA | ₹101 Cr | ₹121 Cr | ₹115 Cr | ₹123 Cr | ₹125 Cr | ₹124 Cr | ₹109 Cr | ₹90 Cr |
| Net Profit | ₹74 Cr | ₹87 Cr | ₹85 Cr | ₹92 Cr | ₹93 Cr | ₹92 Cr | ₹71 Cr | ₹66 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹535 Cr | ₹629 Cr | ₹706 Cr | ₹805 Cr | ₹961 Cr | ₹1,151 Cr | ₹1,435 Cr | ₹1,759 Cr |
| EBITDA | ₹105 Cr | ₹110 Cr | ₹142 Cr | ₹185 Cr | ₹197 Cr | ₹244 Cr | ₹353 Cr | ₹459 Cr |
| Net Profit | ₹71 Cr | ₹65 Cr | ₹96 Cr | ₹136 Cr | ₹147 Cr | ₹179 Cr | ₹258 Cr | ₹339 Cr |
| EPS | 8 | 7.41 | 10.86 | 15.24 | 15.27 | 18.67 | 26.9 | 34.11 |
Balance Sheet
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹565 Cr | ₹654 Cr | ₹767 Cr | ₹1,224 Cr | ₹1,377 Cr | ₹1,577 Cr | ₹1,859 Cr | ₹3,192 Cr |
| Total Liabilities | ₹227 Cr | ₹273 Cr | ₹333 Cr | ₹258 Cr | ₹289 Cr | ₹336 Cr | ₹389 Cr | ₹427 Cr |
| Equity | ₹338 Cr | ₹381 Cr | ₹435 Cr | ₹966 Cr | ₹1,087 Cr | ₹1,242 Cr | ₹1,470 Cr | ₹2,766 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating | ₹98 Cr | ₹134 Cr | ₹166 Cr | ₹163 Cr | ₹171 Cr | ₹249 Cr | ₹340 Cr | ₹333 Cr |
| Investing | ₹-88 Cr | ₹-101 Cr | ₹-109 Cr | ₹-436 Cr | ₹-85 Cr | ₹-179 Cr | ₹-241 Cr | ₹-1,194 Cr |
| Financing | ₹16 Cr | ₹-5 Cr | ₹-21 Cr | ₹317 Cr | ₹-35 Cr | ₹-13 Cr | ₹-20 Cr | ₹951 Cr |
| Free Cash Flow | ₹98 Cr | ₹134 Cr | ₹166 Cr | ₹163 Cr | ₹171 Cr | ₹249 Cr | ₹340 Cr | ₹333 Cr |
Shareholding
Promoter 62.42% Institutions 21.5% Public 16.08%
Efficiency & Working Capital
ROCE12.7%
Interest Coverage32.6
Dividend Payout—
Debtor Days76 d
Inventory Days62 d
Payable Days19 d
Cash Conversion Cycle120 d
Working Capital Days139 d
Shareholding Details
As of 2026-03-31
Promoter62.4%
FII5.9%
DII15.6%
Institutions21.5%
Public16.1%
Promoter Pledge0%
No. of Shareholders73,414
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Dec 2023 | Mar 2024 | Jun 2024 | Aug 2024 | Aug 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 53.2% | 53.1% | 66% | 62.6% | 62.6% | 62.6% | 62.4% | 62.4% | 62.4% | 62.4% | 62.4% | 62.4% |
| FIIs | 14.1% | 12.4% | 9.9% | 11.1% | 11.1% | 11.9% | 12.3% | 11.5% | 11.4% | 9.8% | 9.4% | 5.9% |
| DIIs | 5.3% | 7.2% | 9.3% | 12.5% | 12.5% | 12.3% | 11.7% | 12% | 11.7% | 13.5% | 13.8% | 15.6% |
| Public | 27.5% | 27.3% | 14.7% | 13.9% | 13.9% | 13.2% | 13.6% | 14.1% | 14.4% | 14.3% | 14.3% | 16.1% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 36,053 | 36,712 | 36,852 | 40,516 | 40,516 | 38,352 | 60,686 | 65,583 | 71,142 | 64,400 | 67,750 | 73,414 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Ezekiel Global Business Solutions Llp | Shareholding of Promoter and Promoter Group | 12.2% | 1.24 Cr |
| Rishi Baid | Shareholding of Promoter and Promoter Group | 9.6% | 97,16,356 |
| Zetta Matrix Consulting Llp | Shareholding of Promoter and Promoter Group | 8.2% | 83,22,160 |
| Himanshu Baid | Shareholding of Promoter and Promoter Group | 7.8% | 79,07,624 |
| Quant Mutual Fund - Qsif Hybrid Long-short Fund | Public Shareholding | 4.6% | 46,73,549 |
| Himanshu Baid (huf) | Shareholding of Promoter and Promoter Group | 3.8% | 38,39,200 |
| Vcb Trading Llp | Shareholding of Promoter and Promoter Group | 3.5% | 35,41,144 |
| Jai Polypan Pvt. Ltd. | Shareholding of Promoter and Promoter Group | 3.3% | 33,02,000 |
| Smt.mukulika Baid | Shareholding of Promoter and Promoter Group | 3% | 30,62,400 |
| Rishi Baid (huf) | Shareholding of Promoter and Promoter Group | 2.7% | 27,80,000 |
| Lighthouse India Fund Iv Aif | Public Shareholding | 2.3% | 23,61,087 |
| Axis Max Life Insurance Limited A/c Uegfh - High Growth Fund Ii | Public Shareholding | 2.3% | 23,53,458 |
| Jugal Kishore Baid | Shareholding of Promoter and Promoter Group | 2.3% | 22,79,376 |
| Vishal Baid | Shareholding of Promoter and Promoter Group | 1.7% | 16,81,360 |
| Nirmala Vinodkumar Daga | Public Shareholding | 1.6% | 16,34,019 |
| Uti-unit Linked Insurance Plan | Public Shareholding | 1.5% | 15,20,794 |
| Sbi Nifty 500 Index Fund | Public Shareholding | 1.2% | 12,30,868 |
| Shaily Baid | Shareholding of Promoter and Promoter Group | 1.2% | 11,88,000 |
| Shireen Baid | Shareholding of Promoter and Promoter Group | 1.1% | 11,21,600 |
| Kanchan Pramodkumar Daga | Public Shareholding | 1.1% | 10,65,506 |
| Neha Baid | Shareholding of Promoter and Promoter Group | 1% | 10,24,000 |
| Dhruv Baid | Shareholding of Promoter and Promoter Group | 0.4% | 3,60,000 |
| Aaryaman Baid | Shareholding of Promoter and Promoter Group | 0.3% | 2,80,000 |
| Arham Baid | Shareholding of Promoter and Promoter Group | 0.3% | 2,80,000 |
| Madhu Kothari | Shareholding of Promoter and Promoter Group | 0.2% | 1,51,200 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Himanshu Baid (huf) | 0 | 0% | 2026-03-31 |
| Rishi Baid (huf) | 0 | 0% | 2026-03-31 |
| Smt.mukulika Baid | 0 | 0% | 2026-03-31 |
| Jugal Kishore Baid | 0 | 0% | 2026-03-31 |
| Bhupendra Raj Mehta | 0 | 0% | 2026-03-31 |
| Rishi Baid | 0 | 0% | 2026-03-31 |
| Vishal Baid | 0 | 0% | 2026-03-31 |
| Himanshu Baid | 0 | 0% | 2026-03-31 |
| Shaily Baid | 0 | 0% | 2026-03-31 |
| Shireen Baid | 0 | 0% | 2026-03-31 |
| Neha Baid | 0 | 0% | 2026-03-31 |
| Dhruv Baid | 0 | 0% | 2026-03-31 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Devendra Raj Mehta | Chairman(Non Exe)&Dir(Non-Ind) | 2025 |
| Himanshu Baid | Executive Director & MD | 2025 |
| Jugal Kishore Baid | Non Executive Director | 2025 |
| Rishi Baid | Joint MD & Executive Director | 2025 |
| Alessandro Balboni | Non-Exec & Non-Independent Dir | 2025 |
| Amit Khosla | Independent Non Exe. Director | 2025 |
| Sonal Mattoo | Independent Non Exe. Director | 2025 |
| Ambrish Mithal | Independent Non Exe. Director | 2025 |
| Vimal Bhandari | Independent Non Exe. Director | 2025 |
| Vishal Gupta | Independent Non Exe. Director | 2025 |
| Avinash Chandra | Company Sec. & Compli. Officer | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Medical Devices | ₹629 Cr | 100% |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| With in India | ₹484 Cr | 30.5% |
| Outside India | ₹1,103 Cr | 69.5% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹5 | 60 | 51 | 51 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| dividend | 2025-09-18 | ₹3.5 (70%) | Final |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 23 | 10 | 0 | 48 | 116 | 203 |
| 2025 | 3 | 0 | 0 | 0 | 0 | 3 |
| 2025 | 0 | 1 | 0 | 0 | 89 | 91 |
Insider / Designated-Person Trades
5 recent disclosure(s)
RISHI BAIDDisposal · 24,950
RISHI BAIDDisposal · 99,264
RISHI BAIDDisposal · 30,000
RISHI BAIDDisposal · 60,000
RISHI BAIDDisposal · 10,000
Substantial Acquisitions (SAST)
1 disclosure(s)
Scheme Of Amalgamation26/06/2024 · 1,23,61,320
Company Information
Incorporated1995
ChairmanDevendra Raj Mehta
AuditorDoogar & Associates
Investor Email[email protected]; [email protected]
📍 Property No 232B 3rd Floor, Okhla Indl Estate Phase-III, New Delhi, New Delhi, 110020
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search